107 related articles for article (PubMed ID: 8386713)
1. Clerocidin, a terpenoid antibiotic, inhibits bacterial DNA gyrase.
McCullough JE; Muller MT; Howells AJ; Maxwell A; O'Sullivan J; Summerill RS; Parker WL; Wells JS; Bonner DP; Fernandes PB
J Antibiot (Tokyo); 1993 Mar; 46(3):526-30. PubMed ID: 8386713
[No Abstract] [Full Text] [Related]
2. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.
Wu P; Lawrence LE; Denbleyker KL; Barrett JF
Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365
[TBL] [Abstract][Full Text] [Related]
3. DNA gyrase as a drug target.
Maxwell A
Biochem Soc Trans; 1999 Feb; 27(2):48-53. PubMed ID: 10093705
[No Abstract] [Full Text] [Related]
4. The inhibition of supercoiling activity of DNA gyrase from Micrococcus luteus caused by rufloxacin (MF 934) and MF 961.
Fabbri S; Broggini M; Pagella P; D'Incalci M
J Antimicrob Chemother; 1991 May; 27(5):687-9. PubMed ID: 1653205
[No Abstract] [Full Text] [Related]
5. Unique biological properties and molecular mechanism of 5,6-bridged quinolones.
Macinga DR; Renick PJ; Makin KM; Ellis DH; Kreiner AA; Li M; Rupnik KJ; Kincaid EM; Wallace CD; Ledoussal B; Morris TW
Antimicrob Agents Chemother; 2003 Aug; 47(8):2526-37. PubMed ID: 12878515
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
Nakada N; Gmünder H; Hirata T; Arisawa M
Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus.
Hoshino K; Sato K; Une T; Osada Y
Antimicrob Agents Chemother; 1989 Oct; 33(10):1816-8. PubMed ID: 2556080
[TBL] [Abstract][Full Text] [Related]
8. 4-quinolones and the physiology of DNA gyrase.
Drlica K; Kreiswirth B
Adv Pharmacol; 1994; 29A():263-83. PubMed ID: 7826862
[No Abstract] [Full Text] [Related]
9. Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis.
Onodera Y; Tanaka M; Sato K
J Antimicrob Chemother; 2001 Apr; 47(4):447-50. PubMed ID: 11266418
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal assays for fluoroquinolones.
Gootz TD
Methods Mol Biol; 2001; 95():185-94. PubMed ID: 11089231
[No Abstract] [Full Text] [Related]
11. Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
Strahilevitz J; Robicsek A; Hooper DC
Antimicrob Agents Chemother; 2006 Feb; 50(2):600-6. PubMed ID: 16436716
[TBL] [Abstract][Full Text] [Related]
12. Effect of the efflux pump inhibitor Phe-Arg-beta-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin.
Sáenz Y; Ruiz J; Zarazaga M; Teixidó M; Torres C; Vila J
J Antimicrob Chemother; 2004 Mar; 53(3):544-5. PubMed ID: 14762057
[No Abstract] [Full Text] [Related]
13. Activity of KB-5246 against outer membrane mutants of Escherichia coli and Salmonella typhimurium.
Kotera Y; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1990 Jul; 34(7):1323-5. PubMed ID: 2167038
[TBL] [Abstract][Full Text] [Related]
14. Stereo (C7)-dependent topoisomerase II inhibition and tumor growth suppression by a new quinolone, BO-2367.
Yoshinari T; Mano E; Arakawa H; Kurama M; Iguchi T; Nakagawa S; Tanaka N; Okura A
Jpn J Cancer Res; 1993 Jul; 84(7):800-6. PubMed ID: 8396568
[TBL] [Abstract][Full Text] [Related]
15. Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition.
Takei M; Fukuda H; Kishii R; Hosaka M
Antimicrob Agents Chemother; 2001 Dec; 45(12):3544-7. PubMed ID: 11709337
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antimicrobial, cytotoxic and E. coli DNA gyrase inhibitory activities of coumarinyl amino alcohols.
Priyanka ; Singh V; Ekta ; Katiyar D
Bioorg Chem; 2017 Apr; 71():120-127. PubMed ID: 28196603
[TBL] [Abstract][Full Text] [Related]
17. Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance.
Hooper DC
Clin Infect Dis; 1998 Aug; 27 Suppl 1():S54-63. PubMed ID: 9710672
[TBL] [Abstract][Full Text] [Related]
18. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
Chen CR; Malik M; Snyder M; Drlica K
J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
[TBL] [Abstract][Full Text] [Related]
19. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
[TBL] [Abstract][Full Text] [Related]
20. CJ-12,373, a novel topoisomerase II inhibitor: fermentation, isolation, structure elucidation and biological activities.
Inagaki T; Kaneda K; Suzuki Y; Hirai H; Nomura E; Sakakibara T; Yamauchi Y; Huang LH; Norcia M; Wondrack LM; Sutcliffe JA; Kojima N
J Antibiot (Tokyo); 1998 Feb; 51(2):112-6. PubMed ID: 9544930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]